journal
Journals Therapeutic Advances in Respir...

Therapeutic Advances in Respiratory Disease

https://read.qxmd.com/read/38698565/albuterol-budesonide-fixed-dose-combination-rescue-inhaler-for-asthma-a-plain-language-summary-of-the-mandala-study
#1
REVIEW
Alberto Papi, Bradley E Chipps, Richard Beasley, Reynold A Panettieri, Elliot Israel, Mark Cooper, Lynn Dunsire, Allison Jeynes-Ellis, Robert Rees, Frank C Albers, Christy Cappelletti
What is this summary about? This summary describes the results of a clinical study called MANDALA that was published in the New England Journal of Medicine in 2022. In the MANDALA study, researchers looked at a new asthma rescue inhaler that contains both albuterol and budesonide in a single inhaler (known as albuterol-budesonide , AIRSUPRA™). This summary describes the results for people aged 18 yearsand older who took part in the study.
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38676370/impression-life-with-pulmonary-hypertension-clinically-relevant-characteristics-and-quality-of-life-among-patients-in-gansu-china
#2
JOURNAL ARTICLE
Juxia Zhang, Yujie Wen, Yuhuan Yin, Yiyin Zhang, Rong Zhang, Xiaoli Zhang, Jianying Ye, Yuping Feng, Hongyan Meng
BACKGROUND: The adverse effects of pulmonary arterial hypertension (PAH) on physical, emotional, and health-related quality of life (HRQoL) remain primarily unrecognized, especially in resource-limited settings. OBJECTIVES: This study aims to characterize the HRQoL of patients with PAH in this area and also identify the potential role of clinically relevant characteristics, including the 6-min walk distance test (6MWD), WHO-Functional Classification (WHO-FC), and mental health in the occurrence of lowering quality of life...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38660953/effects-of-a-pulmonary-rehabilitation-program-on-pulmonary-function-exercise-performance-and-quality-of-life-in-patients-with-severe-covid-19
#3
JOURNAL ARTICLE
María Fernanda Del Valle, Jorge Valenzuela, Claudio Bascour-Sandoval, Gabriel Nasri Marzuca-Nassr, Mariano Del Sol, Constanza Díaz Canales, Máximo Escobar-Cabello, Rodrigo Lizama-Pérez, Fernando Valenzuela-Aedo, Rodrigo Muñoz-Cofré
BACKGROUND: Severe coronavirus 2019 disease (COVID-19) causes acute hypoxemic respiratory failure requiring invasive mechanical ventilation (IMV). Once these symptoms are resolved, patients can present systemic deterioration. OBJECTIVE: The two objectives of this study were as follows: to describe the results of a pulmonary rehabilitation program (PRP), which is divided into three groups with different numbers of sessions (12, 24, and 36), and to associate the variables of pulmonary function, exercise performance, and functionality with the number of sessions and functional improvement...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38659187/optimal-flow-of-high-flow-nasal-cannula-oxygenation-to-prevent-desaturation-during-sedation-for-bronchoscopy-a-randomized-controlled-study
#4
RANDOMIZED CONTROLLED TRIAL
Wen Zhang, Xiaohong Yuan, Yajian Shen, Jiangling Wang, Kangjie Xie, Xinzhong Chen
BACKGROUND: Although high-flow nasal cannula (HFNC) oxygenation is currently recommended to prevent desaturation during sedation for bronchoscopy, there is no consensus on an optimal flow rate. OBJECTIVE: To determine the optimal oxygen flow rate for HFNC to effectively prevent desaturation during sedation for bronchoscopy. DESIGN: Prospective, randomized, and controlled study. METHODS: Patients ( n  = 240) scheduled for bronchoscopy were randomized to receive HFNC with propofol sedation (fraction of inspired oxygen, 100%) at one of six flow rates of 10, 20, 30, 40, 50, and 60 L/min, designated as groups 1-6, respectively...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38616385/novel-application-of-nanomedicine-for-the-treatment-of-acute-lung-injury-a-literature-review
#5
REVIEW
Xianfeng Chen, Zhanhong Tang
Nanoparticles have attracted extensive attention due to their high degree of cell targeting, biocompatibility, controllable biological activity, and outstanding pharmacokinetics. Changing the size, morphology, and surface chemical groups of nanoparticles can increase the biological distribution of agents to achieve precise tissue targeting and optimize therapeutic effects. Examples of their use include nanoparticles designed for increasing antigen-specific immune responses, developing vaccines, and treating inflammatory diseases...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38554035/perceived-burden-of-respiratory-physiotherapy-in-people-with-cystic-fibrosis-taking-elexacaftor-tezacaftor-ivacaftor-combination-a-1-year-observational-study
#6
JOURNAL ARTICLE
Chiara Blardone, Simone Gambazza, Alessandra Mariani, Rachele Galgani, Anna Brivio, Rita Maria Nobili, Carmela Rizza, Anna Luisa Tutino, Andrea Gramegna, Valeria Daccò, Martina Contarini, Francesco Blasi, Dario Laquintana
BACKGROUND: To limit the progression of disease, people with cystic fibrosis (pwCF) perform daily respiratory physiotherapy, which is perceived as the most burdensome routine in managing their condition. The elexacaftor-tezacaftor-ivacaftor (ETI) combination has changed respiratory management. OBJECTIVE: To investigate how the perceived treatment burden changed in 1 year of treatment with ETI. DESIGN: Prospective observational study...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38529640/associations-of-prior-pulmonary-tuberculosis-with-the-incident-copd-a-prospective-cohort-study
#7
JOURNAL ARTICLE
Zhilin Zeng, Huilong Chen, Zhonghe Shao, Yunlong Guan, Yuan Zhan, Xi Cao, Si Li, Xingjie Hao
BACKGROUND: Prior pulmonary tuberculosis (PTB) might be associated with the development of chronic obstructive pulmonary disease (COPD). However, the impact of prior PTB on the risk of incident COPD has not been studied in a large prospective cohort study of the European population. OBJECTIVES: This study aimed to investigate the association of prior PTB with the risk of COPD. DESIGN: Prospective cohort study. METHODS: A multivariable Cox proportional model was used to estimate the hazard ratio (HR) and 95% confidence interval (95% CI) for the association of prior PTB with COPD...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38504551/a-review-of-the-therapeutic-potential-of-the-cysteinyl-leukotriene-antagonist-montelukast-in-the-treatment-of-bronchiolitis-obliterans-syndrome-following-lung-and-hematopoietic-stem-cell-transplantation-and-its-possible-mechanisms
#8
REVIEW
Nastaran Kordjazy, Shahideh Amini
Lung and hematopoietic stem cell transplantation are therapeutic modalities in chronic pulmonary and hematological diseases, respectively. One of the complications in these patients is the development of bronchiolitis obliterans syndrome (BOS). The efficacy and safety of available treatment strategies in BOS remain a challenge. A few mechanisms have been recognized for BOS in lung transplant and graft- versus -host disease (GVHD) patients involving the TH-1 and TH-2 cells, NF-kappa B, TGF-b, several cytokines and chemokines, and cysteinyl leukotrienes (CysLT)...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38501735/patient-reported-experiences-with-refractory-or-unexplained-chronic-cough-a-qualitative-analysis
#9
JOURNAL ARTICLE
Vishal Bali, Jonathan Schelfhout, Mandel R Sher, Anju Tripathi Peters, Gayatri B Patel, Margaret Mayorga, Diana Goss, Carla DeMuro Romano
BACKGROUND: Chronic cough, defined as a cough lasting 8 or more weeks, affects up to 10% of adults. Refractory chronic cough (RCC) is a cough that is uncontrolled despite comprehensive investigation and treatment of comorbid conditions while unexplained chronic cough (UCC) is a cough with no identifiable cause despite extensive evaluation of comorbid conditions. RCC and UCC are often poorly controlled. Understanding individuals' lived experience of the symptoms and impacts of these conditions may guide therapeutic strategies...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38465828/all-cause-and-cause-specific-mortality-by-spirometric-pattern-and-sex-a-population-based-cohort-study
#10
JOURNAL ARTICLE
Helena Backman, Sami Sawalha, Ulf Nilsson, Linnea Hedman, Caroline Stridsman, Lowie E G W Vanfleteren, Bright I Nwaru, Nikolai Stenfors, Eva Rönmark, Anne Lindberg
BACKGROUND: Chronic airway obstruction (CAO) and restrictive spirometry pattern (RSP) are associated with mortality, but sex-specific patterns of all-cause and specific causes of death have hardly been evaluated. OBJECTIVES: To study the possible sex-dependent differences of all-cause mortality and patterns of cause-specific mortality among men and women with CAO and RSP, respectively, to that of normal lung function (NLF). DESIGN: Population-based prospective cohort study...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38414439/impact-of-antifibrotic-therapy-on-disease-progression-all-cause-mortality-and-risk-of-acute-exacerbation-in-non-ipf-fibrosing-interstitial-lung-diseases-evidence-from-a-meta-analysis-of-randomized-controlled-trials-and-prospective-controlled-studies
#11
JOURNAL ARTICLE
De-Yu Li, Xin Liu, Jing-Yi Huang, Wen-Lu Hang, Gu-Ran Yu, Yong Xu
BACKGROUND: Nintedanib and pirfenidone are preferred pharmacological therapies for patients with idiopathic pulmonary fibrosis (IPF). However, evidence favoring antifibrotic therapy in patients with non-IPF fibrosing interstitial lung diseases (ILD) is limited. OBJECTIVE: To investigate the effects of antifibrotic therapy on disease progression, all-cause mortality, and acute exacerbation (AE) risk in patients with non-IPF fibrosing ILDs. DESIGN: Meta-analysis...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38409856/optimal-short-term-outcomes-in-balloon-pulmonary-angioplasty-the-minimum-frequency-of-three-sessions-annually
#12
JOURNAL ARTICLE
Xin Li, Tao Yang, Yi Zhang, Qing Zhao, Qixian Zeng, Qi Jin, Anqi Duan, Zhihua Huang, Meixi Hu, Sicheng Zhang, Luyang Gao, Changming Xiong, Qin Luo, Zhihui Zhao, Zhihong Liu
BACKGROUND: Balloon pulmonary angioplasty (BPA) is typically performed in a sequential manner. OBJECTIVES: This study aimed to determine the lowest frequency of BPA for patients who could not reach treatment goals in a short period. DESIGN: Retrospective cohort. METHODS: We retrospectively enrolled 186 BPA-treated patients diagnosed with chronic thromboembolic pulmonary hypertension. According to the accumulative number of performed BPA sessions or treated pulmonary vessels or the ratio of the number of treated pulmonary vessels/the number of baseline lesions (T/P) prior to the initial occurrence of clinical outcome or censored date, we divided patients into different groups...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38409774/ability-of-the-modified-nutric-score-to-predict-mortality-in-patients-requiring-short-term-versus-prolonged-acute-mechanical-ventilation-a-retrospective-cohort-study
#13
JOURNAL ARTICLE
Wanho Yoo, Hyojin Jang, Hayoung Seong, Saerom Kim, Soo Han Kim, Eun-Jung Jo, Jung Seop Eom, Kwangha Lee
BACKGROUND: The modified NUTRIC (nutritional risk in the critically ill) score has been reported to predict clinical outcomes in critically ill patients. However, the applicability of this score may differ between patients undergoing short-term mechanical ventilation (STMV, < 96 h) and those undergoing prolonged acute mechanical ventilation (PAMV, ⩾96 h), as PAMV patients typically experience significantly higher morbidity and mortality. OBJECTIVE: This study aimed to investigate the predictive ability of modified NUTRIC score for predicting 28-day mortality in patients receiving STMV and PAMV...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38409671/role-of-alveolar-nitric-oxide-in-gastroesophageal-reflux-associated-cough-prospective-observational-study
#14
JOURNAL ARTICLE
Li Zhang, Mengru Zhang, Alimire Aierken, Ran Dong, Qiang Chen, Zhongmin Qiu
BACKGROUND: Fractional exhaled nitric oxide (FeNO) measured at multiple exhalation flow rates can be used as a biomarker to differentiate central and peripheral airway inflammation. However, the role of alveolar nitric oxide (CaNO) indicating peripheral airway inflammation remains unclear in gastroesophageal reflux-associated cough (GERC). OBJECTIVES: We aimed to characterize the changes in alveolar nitric oxide (CaNO) and determine its clinical implication in GERC...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38372128/a-real-world-study-of-quality-of-life-following-treatment-with-xylometazoline-hydrochloride-in-individuals-with-common-cold
#15
JOURNAL ARTICLE
Martina Hagen, Kim Clark, Pranab Kalita, Gessica Serra, Edwin Sanchez, Gabor Varbiro, Mathieu M Albasser
BACKGROUND: The common cold is a frequent, acute, and mild upper respiratory human disease. Nasal congestion has been considered the most bothersome symptom in the common cold, impacting quality of life (QoL). Topical decongestants containing steroids benefit QoL in allergic rhinitis, but no published research has assessed the impact of topical decongestants on QoL in the common cold. OBJECTIVE: To evaluate the effects of xylometazoline hydrochloride 0.1% (Otrivin, GSK Consumer Healthcare SARL, Switzerland) for up to 7 days on QoL in participants with nasal congestion associated with the common cold...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38357903/the-diagnostic-journey-of-pulmonary-arterial-hypertension-patients-results-from-a-multinational-real-world-survey
#16
JOURNAL ARTICLE
Mark Small, Loïc Perchenet, Alex Bennett, Jörg Linder
BACKGROUND: Pulmonary arterial hypertension (PAH) is a life-threatening, progressive disease often diagnosed late in its course. OBJECTIVES: To present patient-reported data that were captured within a large, multinational, point-in-time survey of PAH-treating physicians and their patients to better understand the diagnostic journey. DESIGN: Cross-sectional survey conducted in five European countries (EU5), Japan and the USA. METHODS: PAH-treating pulmonologists, cardiologists, rheumatologists or internists (USA only) completed a patient record form (PRF) for the next four consecutive adult PAH patients they saw; these patients filled in a patient self-completion (PSC) form on an anonymous, voluntary basis...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38357899/early-experience-of-endobronchial-ultrasound-guided-transbronchial-nodal-cryobiopsy-a-case-series-from-sabah-malaysia
#17
JOURNAL ARTICLE
Hema Yamini Ramarmuty, Nai-Chien Huan, Larry Ellee Nyanti, Teng Shin Khoo, Tamilarasi Renganathan, Ahmad Zaki Manoh, Nusaibah Azman, Kunji Kannan Sivaraman Kannan
Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is an established minimally invasive method for the diagnosis of benign and malignant conditions. Continuous efforts are underway to improve the material adequacy of EBUS-TBNA, including the introduction of a new technique called EBUS-guided transbronchial nodal cryobiopsy (EBUS-TBNC). This method allows for the retrieval of larger and well-preserved histologic samples from the mediastinum. We present a case series of four patients who underwent combined EBUS-TBNA and EBUS-TBNC procedures in our centre...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38343122/profile-of-cough-triggers-and-their-relationship-with-capsaicin-cough-sensitivity-in-chronic-cough
#18
JOURNAL ARTICLE
Tingting Xu, Zhiyin Chen, Chen Zhan, Wenzhi Zhan, Fang Yi, Kefang Lai
BACKGROUND: Cough hypersensitivity is an important part of the neurophysiology of cough, which presents with increased cough response to a lower level of stimuli or triggers. Classification of stimuli might bring about additional insight into the underlying mechanisms and management. OBJECTIVES: This study investigated the profile of cough triggers in chronic cough patients and their relationship with capsaicin cough sensitivity. DESIGN: This was a cross-sectional observational study...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38327061/video-assisted-thoracoscopic-surgery-for-non-cystic-fibrosis-bronchiectasis-in-children
#19
JOURNAL ARTICLE
Fengxia Ding, Zhengxia Pan, Chun Wu, Hongbo Li, Yonggang Li, Yong An, Jiangtao Dai, Gang Wang, Bo Liu
BACKGROUND: Pediatric bronchiectasis is a common respiratory disease in children. The use of video-assisted thoracoscopic surgery (VATS) for its treatment remains controversial. OBJECTIVES: The objective of our study was to compare and analyze the clinical efficacy of thoracoscopic surgery and thoracotomy in the treatment of pediatric bronchiectasis and summarize the surgical treatment experience of VATS in children with bronchiectasis. DESIGN: Retrospective single-center cohort study...
2024: Therapeutic Advances in Respiratory Disease
https://read.qxmd.com/read/38235607/effects-of-omalizumab-on-lung-function-in-patients-with-moderate-to-severe-allergic-asthma-a-systematic-review-and-meta-analysis
#20
JOURNAL ARTICLE
Junyi Liao, Jia Tang, Yuanping Jiang, Youwen Wang, Jiali Ding, Yong He
BACKGROUND: With the rise of targeted treatments for asthma, treatment with omalizumab is a new option. OBJECTIVES: To assess the improvement of pulmonary function with additional omalizumab treatment in patients (⩾6 years old) with moderate-to-severe allergic asthma. DATA SOURCES AND METHODS: Observational studies of randomized controlled trials of add-on omalizumab for the treatment of patients with moderate-to-severe allergic asthma, published from the establishment till August 2022, were retrieved from WAN FANG DATA, PubMed, CNKI, Embase, Cochrane, and Web of Science databases...
2024: Therapeutic Advances in Respiratory Disease
journal
journal
41742
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.